|
||||||||||||||||
|
||||||||||||||||
| HUM-MOLGEN -> mail archive | Search | register for news alert (free) | |||||||||||||||
| Agnes Tay: posting | ||||||||||||||||
|
[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index] |
||||||||||||||||
|
To: HUM-MOLGEN@NIC.SURFNET.NL Subject: posting From: Agnes Tay <mcbtayhn@leonis.nus.sg> Date: Wed, 4 Jun 1997 08:29:05 +0500
*************************************************************
HUM-MOLGEN DIAGnostics/Clinical Research
**************************************************************
This DIAG message contains 3 submessage(s),1 patient request:
1. Parkinson's Cluster
2. Microtia
3. NF2--Pt Request
Carlo Gambacorti MD, Editor, Agnes Tay, MD PhD, Asst Editor
Human Molecular Genetics Network
Diagnostics/Clinical Research Section
========================================================================
1. Parkinson's Cluster
Is there evidence for a genetic component to Parkinson's Disease? I have
just learned of a cluster of 12 individuals who might be related by a
founder effect. Any information would be appreciated.
Bob Pollack
<pollack@clumbia.edu>
Robert E Pollack
Professor, Dept of Biological Sciences
749 Fairchild Laboratory
1212 Amsterdam Avenue
mailcode 2419
Columbia University
New York NY 10027
phone: 212 854 2409
fax: 212 854 0897
============================================================
2. Microtia
I've just seen two unrelated Latin American patients with isolated
bilateral Microtia III (no spinal anomalies, no facial dysmorphism). The
first, a little boy, has no family history, and the family was given a low
recurrence risk. The second, a little girl has a distant family history
(father's mother's sister and that person's child) of _unilateral_
microtia. I have examined the father and his ears are normal. He reports
that his mother's ears also are normal. Literature is all over the board.
I would appreciate any advice regarding couseling this family on recurrence
risk. Based upon what I have found, I am inclined towards telling them
that their empiric risk is about 5%, but that it may be as high as 50%.
Angela E. Scheuerle, M.D.
Assistant Professor
Division of Medical Genetics
Department of Pediatrics
UT Health Science Center - Houston
6431 Fannin, MSB 3.144
Houston TX 77030
ascheuer@ped1.med.uth.tmc.edu
============================================================
3.NF2--Patient Request
Apparent Pt Location: England
PLEASE REPLY DIRECTLY TO HUM-MOLGEN
Dear all,
I am keen to know as much as possible about the latest research
into NF2. I am a patient of the disorder, and would appreciate any
information
particularly about new forms of (non-surgical) treatment.
==================================================================
|
||||||||||||||||
|
||||||||||||||||
|
Mail converted by |
||||||||||||||||